Association between sedation drugs and delirium in patients undergoing extracorporeal membrane oxygenation: a single-center retrospective study
Open Access
- 1 February 2026
- journal article
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (2) , 109
Abstract
Background: Delirium is a frequent and serious complication in critically ill patients, particularly those receiving extracorporeal membrane oxygenation (ECMO), and is associated with increased morbidity and mortality. This study aimed to evaluate the association between different sedation drugs and the occurrence of delirium in patients receiving ECMO, as well as to explore other potential risk factors by analyzing baseline characteristics and laboratory findings. Methods: A retrospective cohort study was conducted on patients receiving ECMO who were monitored for delirium. Baseline characteristics, laboratory findings, and the duration and types of sedative drugs used were analyzed to determine their association with delirium. Logistic regression analysis was performed to evaluate the effect of sedatives on delirium risk. Results: Of the 51 patients on ECMO (mean age: 56 years; males: 39), 34 developed delirium, while 17 did not. Significant differences were observed in the use of tracheostomy and sedative drug combinations between groups. Logistic regression revealed that midazolam was associated with a significantly higher risk of delirium (odds ratio: 15.39, 95% confidence interval: 2.14–110.70), whereas sufentanil and dexmedetomidine did not show significant associations. Conclusions: Midazolam use was strongly associated with increased delirium risk in patients on ECMO, whereas sufentanil and dexmedetomidine were not associated with delirium. These findings highlight the importance of sedative management in critically ill patients undergoing ECMO.Keywords
This publication has 19 references indexed in Scilit:
- Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled TrialAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Benzodiazepine-associated delirium in critically ill adultsIntensive Care Medicine, 2015
- Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patientsIntensive Care Medicine, 2014
- The Pain, Agitation, and Delirium Care BundleCritical Care Medicine, 2013
- Benzodiazepine Versus Nonbenzodiazepine-Based Sedation for Mechanically Ventilated, Critically Ill AdultsCritical Care Medicine, 2013
- Sedation for Critically Ill or Injured Adults in the Intensive Care UnitDrugs, 2012
- Pharmacology of Sedative-Analgesic Agents: Dexmedetomidine, Remifentanil, Ketamine, Volatile Anesthetics, and the Role of Peripheral Mu AntagonistsCritical Care Clinics, 2009
- Incidence, risk factors and consequences of ICU deliriumIntensive Care Medicine, 2006
- Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patientsCritical Care, 2005
- A Multicomponent Intervention to Prevent Delirium in Hospitalized Older PatientsNew England Journal of Medicine, 1999